Renaissance Capital logo
IPO Center

Minerva Neurosciences Priced, Nasdaq: NERV

Clinical-stage biotech developing treatments for central nervous system diseases.

Industry: Health Care

First Day Return: +0.8%

Clinical-stage biotech developing treatments for central nervous system diseases.
IPO Data
IPO Date 06/30/2014
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $33
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Cambridge, MA, United States
Founded 2007
Employees at IPO 6
Website www.minervaneurosciences.com

Minerva Neurosciences (NERV) Performance

Created with Highcharts 10.3.2Chart context menuNERV vs. IPO Index (IPOUSA)20152016201720182019202020212022202320242025-100%0%+ 100%+ 200%+ 300%View 5 days5dView 1 month1mView 3 months3mView year to dateYTDView 1 year1yView allAllRenaissance IPO IndexOur ETF tracks the IPO Index

Follow Us

IPO ETFs

IPO Center

IPO Pro

IPO Intelligence

IPO Data

About Us

Important Disclosures
Renaissance Capital LLC is an SEC-registered investment adviser.
© 2025 Renaissance Capital LLC. All rights reserved.